Company intelligence / Profile preview

Vascular Access Technologies

Billerica, Massachusetts, United States

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Access Vascular’s PICC and midline catheters using MIMIX® technology have demonstrated statistically significant reduction in complications (including thrombosis rates) versus conventional catheters in clinical, in vivo, and in vitro studies; specific HydroMID midline catheter data presented at AVA 2024 showed significantly lower complication rates

Therapeutic areas: CardiovascularOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Capstone Health Alliance (strategic group purchasing partnership for hospital distribution)

Beyond the preview

Go deeper on Vascular Access Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular Access Technologies.

Explore the full profile